Pharmafile Logo

Event: World Pharma Pricing and Market Access Congress

May 2, 2019 | Pharma, healthcare 

Directors Brett Gardiner and Rachel Howard attended the World Pharma Pricing and Market Access Congress in Amsterdam in March.

This two-day event was attended by over 600 delegates, including a number of payers from Europe, the US and Latin America, plus representatives from the industry and other market access organizations. In the morning plenary sessions, we heard a range of perspectives on value, demonstrating that “value is in the eye of the beholder”. A major focus was the new challenges facing Health Technology Assessment (HTA) organizations in view of the expanding pipeline of Advanced Therapy Medicinal Products (ATMPs) such as cell and gene therapy. There was much discussion about how these products, with their high upfront costs and inherent limitations will necessitate the creation of a new access model. To allow negotiations to move forward and ensure more timely access to patients, we need to look at using innovative payment models such as outcomes-based contracting and find ways of addressing uncertainty.

Find out more about their time at the event.

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

A guide to measuring and tracking brand KPIs

Dr Allison Fleetwood, Director of Therapy Watch, alongside Associate Director Jennifer Redfearn, recently delivered a workshop on measuring and tracking brand KPIs as part of the BHBIA training programme (www.bhbia.org.uk).

Electronic medical records and doctor/patient communication

View from the US: When I talk to family members or friends who are physicians these days, I hear a lot of complaints.

Statistics and bikinis – 2 men united

I want to write today about 2 men that between them have reminded me of a fine line that we have to tread every time we analyse a dataset...

Eliminating Stigma: A consideration of the role the pharmaceutical industry can play

My recent article in Medical Marketing & Media explored the importance of vaccine perceptions in a self-pay market and touched upon the issue of stigma, with the recognition that some diseases or...

Fighting talk

One thing that grasps my interest is how society has adopted military style language when talking about cancer

Is MINT the next BRIC?

In 2001, British economist Jim O’Neill coined the now ubiquitous acronym ‘BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, which he suggested were all...

The healthcare market research themes for 2014

As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.

Big Data—a new player in the Healthcare Industry

Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.

Blog: Affordable Care Act

What does the future hold for the US pharma industry?

Webinar: How to conduct effective market research in emerging markets

Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.